Theratechnologies Shares Surge Premarket on Deal to Go Private

Dow Jones

07/03

By Colin Kellaher

Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million.

Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company.

Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million.

U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading.

The deal is slated to close by the end of November.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

July 03, 2025 06:03 ET (10:03 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2548089628"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548089628\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2548089628?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-03 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548089628","market":"hk","top_or_hot":-1,"title":"Theratechnologies Shares Surge Premarket on Deal to Go Private","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million. \n</p>\n<p>\n  Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company. \n</p>\n<p>\n  Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million. \n</p>\n<p>\n  U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading. \n</p>\n<p>\n  The deal is slated to close by the end of November. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 06:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Theratechnologies Shares Surge Premarket on Deal to Go Private</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTheratechnologies Shares Surge Premarket on Deal to Go Private\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-07-03 18:03</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million. \n</p>\n<p>\n  Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company. \n</p>\n<p>\n  Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million. \n</p>\n<p>\n  U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading. \n</p>\n<p>\n  The deal is slated to close by the end of November. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 06:03 ET (10:03 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"THTX","symbol_name":"Theratechnologies, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2548089628","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548089628","pubTimestamp":1751536980,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million.Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company.Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million.U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading.The deal is slated to close by the end of November.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"THTX":"Theratechnologies, Inc.","BK4139":"生物科技"},"translate_title":"Theratechnologies股价因私有化交易盘前飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THTX":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Shares of Theratechnologies rose sharply in premarket trading Thursday after the biopharmaceutical company agreed to be acquired by privately held pharmaceutical and nutraceutical products maker Future Pak for up to $254 million. \n\n\n  Theratechnologies late Wednesday said Future Pak will pay an initial $3.01 a share in cash for the Montreal company, a nearly 28% premium to Wednesday's closing price of $2.36 for its U.S.-listed shares and more than double its closing price of $1.33 on April 10, the day before Future Pak announced its pursuit of the company. \n\n\n  Theratechnologies investors will also receive contingent value rights worth up to an additional $1.19 a share tied to certain profit milestones, which could bring the total transaction consideration to $4.20 a share, or $254 million. \n\n\n  U.S.-listed shares of Theratechnologies were recently up 32% at $3.12 in premarket trading. \n\n\n  The deal is slated to close by the end of November. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 03, 2025 06:03 ET (10:03 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}